Csl Vifor Logo (Image 01)
Mircera Injection, Solution
Product Images NDC 59353-402
39 FDA label images from Vifor (international) Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 39 technical images submitted to the FDA as part of the official labeling for Mircera (NDC 59353-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vifor (international) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Image 31)
An instructional diagram illustrating the components of a prefilled syringe with needle assembly. Labeled parts include the plunger, finger grips, tear off label, activation guards, needle safety device, rubber tip cap, needle, cap, and needle shield, showing the syringe structure and safety features.*
Figure B (Image 02)
An instructional diagram showing the parts of an injection device for Mircera (Methoxy polyethylene glycol-epoetin beta). Labeled components include the plunger rod, release clips, expiry date area, tear off label, device body, plastic needle guard, rubber tip cap, needle, cap, and needle shield.*
Figure C (Image 32)
An illustration showing a hand holding a rectangular box with an arrow pointing to an open refrigerator. The image suggests storing the product, likely a medication, in refrigeration.*
Figure D (Image 33)
The image shows a transparent plastic blister packaging containing a single prefilled syringe. The syringe is designed for intravenous injection and corresponds to Mircera (methoxy polyethylene glycol-epoetin beta) injection, solution. The packaging is typical for sterile medical syringes but does not display text or labeling details.*
Figure E (Image 34)
Illustration showing two hands under running water from a faucet, demonstrating hand washing technique. Water flows over one hand while the other hand is being rinsed.*
Figure F (Image 35)
An instructional illustration showing a hand removing a prefilled syringe from its plastic tray packaging. The syringe is positioned slightly above the tray with an arrow indicating upward movement, and another arrow shows the tray's lid being opened.*
Figure G (Image 36)
An instructional illustration showing a hand holding a prefilled syringe labeled with an expiration (EXP.) window, emphasizing the need to visually check the expiration date before use. The diagram highlights eye line-of-sight to the expiration label on the syringe.*
Figure H (Image 37)
An instructional illustration showing hands holding a prefilled syringe labeled Mircera, with one hand gripping the syringe barrel and the other hand removing or twisting off the needle cap before injection.*
Figure I (Image 38)
An instructional illustration showing two hands demonstrating the removal of a protective cap from a syringe, indicated by arrows guiding the motion. The syringe is likely part of the preparation process for Mircera injection solution.*
Figure J (Image 39)
An instructional illustration showing how to remove a cap from a prefilled syringe. The image depicts two hands holding the syringe and cap, with an arrow indicating the direction to twist and pull the cap off before administration.*
Figure K (Image 40)
An instructional anatomical diagram showing recommended injection sites for Mircera injection. The shaded areas indicate the abdomen, upper thigh, and upper arm regions on both the front and back of a human figure where intravenous injection is administered.*
Figure L (Image 41)
An illustration showing a hand using a cloth or wipe to clean or apply pressure on a surface, possibly demonstrating a step in preparing an injection site or cleaning a vial.*
Figure M (Image 42)
Illustration showing a hand holding a syringe filled with liquid and another hand holding a cap or small vial. An arrow between the syringe and cap indicates the action of attaching or removing the cap from the syringe. This relates to the preparation or use of an injection solution product.*
Figure N (Image 43)
Instructional illustration showing the use of a prefilled syringe, with two hands preparing the syringe for injection by twisting or unlocking a component near the plunger. No text or labeling is present on the syringe in the image.*
Figure O (Image 44)
An instructional illustration showing a hand holding a syringe with the thumb pushing the plunger upward, indicating how to administer or prepare an injection.*
Figure P (Image 45)
An instructional diagram showing a hand holding a syringe and injecting solution into a person's arm, illustrating the intravenous route of administration.*
Figure Q (Image 46)
An instructional illustration showing a hand holding a syringe vertically above a surface, possibly demonstrating the technique for administering an injection. The image is related to the intravenous injection dosage form of Mircera (Methoxy polyethylene glycol-epoetin beta).*
Figure R (Image 47)
An instructional illustration showing a hand holding a syringe and lifting the protective cap upward, likely demonstrating how to remove the cap before administration. The syringe has a visible needle at the bottom and a transparent chamber.*
Figure S (Image 48)
An instructional illustration showing a hand holding a syringe-like device with a plunger being pulled back, indicating the process to prepare or draw medication from the syringe. The device includes a spring mechanism visible inside the barrel.*
Figure T (Image 49)
An instructional line drawing showing a hand gripping and pulling back a plastic tab or safety device from the top of a prefilled syringe. The syringe is detailed with a visible plunger, barrel, and needle tip cover, illustrating preparation steps for injection use.*
Figure U (Image 50)
An instructional illustration showing a person seated on a surface applying an injection to the thigh area. The hand is holding a syringe or similar device, targeting the upper thigh region, likely demonstrating the accepted injection site or method.*
Figure A (Image 51)
An instructional illustration showing a hand wiping the cap of a vial or injection port with a cloth or swab, demonstrating aseptic technique for cleaning before use.*
Figure B (Image 52)
An instructional illustration showing hands holding a prefilled syringe of Mircera injection solution and the removal of the protective cap from the needle before administration. The diagram emphasizes proper handling of the syringe for intravenous use.*
Figure C (Image 53)
An instructional illustration showing hands preparing a prefilled syringe with a safety shield or cap, demonstrating the removal or handling of the needle cover for an intravenous injection.*
Figure D (Image 54)
An instructional illustration showing a hand holding an injection device with the thumb pressing the plunger, indicating the direction to push upwards for activation or injection. The image likely demonstrates how to use or operate the injectable medication device.*
Figure E (Image 55)
Illustration showing the correct technique to insert the needle of an injection device vertically downward into a vial stopper or injection port. The image focuses on hand positioning and needle insertion alignment for proper intravascular use.*
Figure F (Image 56)
An instructional illustration showing a hand pressing down on a syringe plunger. The syringe is positioned vertically over a connector or injection site, likely demonstrating the injection or drug administration process. No product branding or text is visible in the image.*
Figure G (Image 57)
An instructional illustration showing a hand holding a prefilled injection syringe. The image depicts the process of preparing or using the syringe, indicated by an arrow pointing outward from the plunger, suggesting the plunger is being pulled or moved.*
Figure H (Image 58)
An instructional diagram showing a hand peeling back a tab or cover from a pre-filled injection device, likely a syringe or auto-injector, with a visible plunger and spring mechanism inside the clear barrel.*
Principal Display Panel (30 mcg / 0.3 mL Carton Label)
Mircera 30 mcg/0.3 mL prefilled syringe label showing the brand name, generic name methoxy polyethylene glycol-epoetin beta, and dosage strength. The label indicates it is a sterile solution for intravenous or subcutaneous use, single-dose only with a 27 gauge needle. The labeler is Vifor Pharma, and storage instructions include keeping refrigerated. The label includes a message for pharmacists about an enclosed Medication Guide.*
Principal Display Panel (50 mcg / 0.3 mL Carton Label)
Mircera 50 mcg / 0.3 mL injection solution label shows the product name and active ingredient (methoxy polyethylene glycol-epoetin beta). It is a sterile solution for intravenous or subcutaneous use only. Packaging includes a single-dose prefilled syringe with a 27 gauge needle. Labeler is Vifor Pharma. Directions to keep refrigerated and a pharmacist medication guide warning are also visible.*
Principal Display Panel (75 mcg / 0.3 mL Syringe Label)
Mircera 75 mcg / 0.3 mL injection solution label for intravenous or subcutaneous use. The label shows the proprietary name Mircera with the generic name methoxy polyethylene glycol-epoetin beta. It is a single-dose prefilled syringe with a 27 gauge needle, requiring refrigeration. Labeler is Vifor Pharma.*
Principal Display Panel (100 mcg / 0.3 mL Syringe Label)
Mircera 100 mcg / 0.3 mL injection solution label for intravenous or subcutaneous use. The label shows methoxy polyethylene glycol-epoetin beta as the active ingredient, with a single-dose prefilled syringe and 27 gauge needle. The labeler is Vifor Pharma. Instructions include refrigerate storage and discarding unused portions.*
Principal Display Panel (120 mcg / 0.3 mL Carton Label)
Label for Mircera injection solution, containing methoxy polyethylene glycol-epoetin beta at 120 mcg/0.3 mL strength. The label indicates single-dose use with a prefilled syringe and 27 gauge needle, for intravenous or subcutaneous administration. It also includes storage instructions to keep refrigerated and is labeled by Vifor Pharma.*
Principal Display Panel (150 mcg / 0.3 mL Syringe Label)
Mircera 150 mcg/0.3 mL injection solution label showing methoxy polyethylene glycol-epoetin beta as the active ingredient. The label indicates it is for intravenous or subcutaneous use, provided in a single-dose prefilled syringe with a 27 gauge needle. The product is distributed by Vifor Pharma and requires refrigeration.*
Principal Display Panel (200 mcg / 0.3 mL Syringe Label)
Mircera 200 mcg / 0.3 mL injection solution label showing methoxy polyethylene glycol-epoetin beta as the active ingredient. The label indicates it is for intravenous or subcutaneous use only, packaged in a single-dose prefilled syringe with a 27 gauge needle. The product is labeled by Vifor Pharma and requires refrigeration.*
Principal Display Panel (250 mcg / 0.3 mL Syringe Label)
Label for Mircera injection, solution containing methoxy polyethylene glycol-epoetin beta at 250 mcg per 0.3 mL. The label indicates it is a sterile solution for intravenous or subcutaneous use, supplied as a single-dose prefilled syringe with a 27 gauge needle. The labeler is Vifor Pharma. Storage instructions include Keep Refrigerated, and it states Rx only.*
Principal Display Panel (360 mcg / 0.6 mL Carton Label)
Mircera 360 mcg / 0.6 mL injection, solution label for methoxy polyethylene glycol-epoetin beta. The label indicates sterile solution for intravenous or subcutaneous use only. It is a single-dose prefilled syringe with a 27 gauge needle. Labeler: Vifor Pharma. The label includes instructions to keep refrigerated and a pharmacist medication guide notice.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
